Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index

키워드

참고문헌 (104)

1. Watanabe S, "Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease", nonalcoholic steatohepatitis, 2015, pp.50, 364~377
2. Wong VW, "Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1 : definition, risk factors and assessment", J Gastroenterol Hepatol, 33, pp.70~85 (2018)
3. Chitturi S, "The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2 : management and special groups", J Gastroenterol Hepatol, 33, pp.86~98 (2018)
4. European Association for the Study of the Liver (EASL), "EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease", J Hepatol, 64, pp.1388~1402 (2016)
5. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
6. Hamaguchi M, "The metabolic syndrome as a predictor of nonalcoholic fatty liver disease", Ann Intern Med, 143, pp.722~728 (2005)
7. Kim HK, "Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans", Am J Med Sci, 337, pp.98~102 (2009)
8. Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", J Gastroenterol Hepatol, 21(1 Pt 1), pp.138~143 (2006)
9. Adams LA, "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
10. Ekstedt M, "Long-term follow-up of patients with NAFLD and elevated liver enzymes", Hepatology, 44, pp.865~873 (2006)
11. Dam-Larsen S, "Final results of a long-term, clinical follow-up in fatty liver patients", Scand J Gastroenterol, 44, pp.1236~1243 (2009)
12. Söderberg C, "Decreased survival of subjects with elevated liver function tests during a 28-year followup", Hepatology, 51, pp.595~602 (2010)
13. Haflidadottir S, "Long-term followup and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease", BMC Gastroenterol, 14, pp.166~ (2014)
14. Angulo P, "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease", Gastroenterology, 149, pp.389~397 (2015)
15. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease : metaanalytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
16. Tada T, "Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease", Hepatol Commun, 1, pp.899~910 (2017)
17. Rafiq N, "Long-term follow-up of patients with nonalcoholic fatty liver", Clin Gastroenterol Hepatol, 7, pp.234~238 (2009)
18. Hashimoto E, "Prevalence, gender, ethnic variations, and prognosis of NASH", J Gastroenterol, 46(Suppl 1), pp.63~69 (2011)
19. Lonardo A, "Sex differences in NAFLD : state of the art and identification of research gaps", Hepatology, 70, pp.1457~1469 (2019)
20. WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
21. Weston SR, "Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease", Hepatology, 41, pp.372~379 (2005)
22. Park YW, "Larger amounts of visceral adipose tissue in Asian Americans", Obes Res, 9, pp.381~387 (2001)
23. Wang J, "Asians have lower body mass index(BMI)but higher percent body fat than do whites : comparisons of anthropometric measurements", Am J Clin Nutr, 60, pp.23~28 (1994)
24. Abate N, "Risk of obesity-related cardiometabolic complications in special populations : a crisis in Asians", Gastroenterology, 152, pp.1647~1655 (2017)
25. Alberti KG, "The metabolic syndrome : a new worldwide definition", Lancet, 366, pp.1059~1062 (2005)
26. Kim D, "Nonobese fatty liver disease", Clin Gastroenterol Hepatol, 15, pp.474~485 (2017)
27. Tobari M, "Characteristics of nonalcoholic steatohepatitis among lean patients in Japan : not uncommon and not always benign", J Gastroenterol Hepatol, 34, pp.1404~1410 (2019)
28. Sookoian S, "Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene(PNPLA3)on the susceptibility and histological severity of nonalcoholic fatty liver disease", Hepatology, 53, pp.1883~1894 (2011)
29. Singal AG, "The effect of PNPLA3on fibrosis progression and development of hepatocellular carcinoma : a meta-analysis", Am J Gastroenterol, 109, pp.325~334 (2014)
30. Shen J, "PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome", Aliment Pharmacol Ther, 39, pp.532~539 (2014)
31. Wei JL, "Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients : a population study using proton-magnetic resonance spectroscopy", Am J Gastroenterol, 110, pp.1306~1314 (2015)
32. Kojima S, "Increase in the prevalence of fatty liver in Japan over the past 12 years : analysis of clinical background", J Gastroenterol, 38, pp.954~961 (2003)
33. Jimba S, "Prevalence of nonalcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults", Diabet Med, 22, pp.1141~1145 (2005)
34. Eguchi Y, "Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan : a multicenter large retrospective study", J Gastroenterol, 47, pp.586~595 (2012)
35. The Japan Society of Hepatology, "Kankohennoseiinbetujittai 2018" (2019), Igakutoshoshuppan
36. Tateishi R, "A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan : 2011-2015 update", J Gastroenterol, 54, pp.367~376 (2019)
37. Hashimoto E, "Hepatocellular carcinoma in nonalcoholic steatohepatitis : growing evidence of an epidemic", Hepatol Res, 42, pp.1~14 (2012)
38. Tokushige K, "Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology : report of the nationwide survey", J Gastroenterol, 46, pp.1230~1237 (2011)
39. Tokushige K, "Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease : multicenter survey", J Gastroenterol, 51, pp.586~596 (2016)
40. Yasui K, "Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma", Clin Gastroenterol Hepatol, 9, pp.428~433 (2011)
41. Tokushige K, "Hepatocellular carcinoma based on cryptogenic liver disease : the most common non-viral hepatocellular carcinoma in patients aged over 80 years", Hepatol Res, 45, pp.441~447 (2015)
42. Taniai M, "Clinicopathological investigation of steatohepatitic hepatocellular carcinoma : a multicenter study using immunohistochemical analysis of adenomarelated markers", Hepatol Res, 48, pp.947~955 (2018)
43. Kawada N, "Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis", J Gastroenterol, 44, pp.1190~1194 (2009)
44. Mittal S, "Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 14, pp.124~131 (2016)
45. Piscaglia F, "Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease : a multicenter prospective study", Hepatology, 63, pp.827~838 (2016)
46. Kanwal F, "Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease", Gastroenterology, 155, pp.1828~1837 (2018)
47. Stine JG, "Systematic review with meta-analysis : risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases", Aliment Pharmacol Ther, 48, pp.696~703 (2018)
48. Kulik L, "Epidemiology and management of hepatocellular carcinoma", Gastroenterology, 156, pp.477~491 (2019)
49. 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
50. Wong RJ, "Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States", Gastroenterology, 148, pp.547~555 (2015)
51. Beste LA, "Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013", Gastroenterology, 149, pp.1471~1482 (2015)
52. Younossi ZM, "Pathologic criteria for nonalcoholic steatohepatitis : interprotocol agreement and ability to predict liver-related mortality", Hepatology, 53, pp.1874~1882 (2011)
53. Ekstedt M, "Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up", Hepatology, 61, pp.1547~1554 (2015)
54. Vilar-Gomez E, "Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease : a multinational cohort study", Gastroenterology, 155, pp.443~457 (2018)
55. Adams LA, "The histological course of nonalcoholic fatty liver disease : a longitudinal study of 103 patients with sequential liver biopsies", J Hepatol, 42, pp.132~138 (2005)
56. Hashimoto E, "Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis : current concepts and remaining challenges", Hepatol Res, 45, pp.20~28 (2015)
57. Yatsuji S, "Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis", Hepatol Res, 37, pp.1034~1043 (2007)
58. Angulo P, "Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis", Hepatology, 30, pp.1356~1362 (1999)
59. Ratziu V, "Liver fibrosis in overweight patients", Gastroenterology, 118, pp.1117~1123 (2000)
60. Fan JG, "What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific", J Gastroenterol Hepatol, 22, pp.794~800 (2007)
61. Okanoue T, "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan", J Gastroenterol Hepatol, 26(Suppl 1), pp.153~162 (2011)
62. Hashimoto E, "Characteristics and diagnosis of NAFLD", NASH, 2013, pp.28(Suppl 4), 64~70
63. Bechtold M, "Metabolic syndrome in the elderly", Curr Diab Rep, 6, pp.64~71 (2006)
64. Wynne HA, "The effect of age upon liver volume and apparent liver blood flow in healthy man", Hepatology, 9, pp.297~301 (1989)
65. Premoli A, "Characteristics of liver diseases in the elderly : a review", Minerva Gastroenterol Dietol, 55, pp.71~78 (2009)
66. Gan L, "Mechanisms and implications of age-related changes in the liver : nonalcoholic fatty liver disease in the elderly", Curr Gerontol Geriatr Res, 2011, pp.831536~ (2011)
67. Floreani A, "Liver diseases in the elderly : an update", Dig Dis, 25, pp.138~143 (2007)
68. Lee YH, "Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease : nationwide surveys(KNHANES 2008-2011)", Hepatology, 63, pp.776~786 (2016)
69. Bhanji RA, "Sarcopenia in hiding : the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis", Hepatology, 66, pp.2055~2065 (2017)
70. Koo BK, "Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis", J Hepatol, 66, pp.123~131 (2017)
71. Kagansky N, "Non-alcoholic fatty liver disease : a common and benign finding in octogenarian patients", Liver Int, 24, pp.588~594 (2004)
72. Koehler EM, "Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly : results from the Rotterdam study", J Hepatol, 57, pp.1305~1311 (2012)
73. Golabi P, "Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States", BMC Gastroenterol, 19, pp.56~ (2019)
74. Wong VW, "Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese : a population study using proton-magnetic resonance spectroscopy and transient elastography", Gut, 61, pp.409~415 (2012)
75. Wang Z, "Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China", Eur J Gastroenterol Hepatol, 26, pp.1015~1021 (2014)
76. Long MT, "A simple clinical model predicts incident hepatic steatosis in a community-based cohort : the Framingham Heart Study", Liver Int, 38, pp.1495~1503 (2018)
77. Zhou YJ, "Prevalence of fatty liver disease and its risk factors in the population of South China", World J Gastroenterol, 13, pp.6419~6424 (2007)
78. Suzuki A, "Nonalcoholic fatty liver disease in women", Womens Health(Lond), 5, pp.191~203 (2009)
79. Clark JM, "Nonalcoholic fatty liver disease", Gastroenterology, 122, pp.1649~1657 (2002)
80. Rettberg JR, "Estrogen : a master regulator of bioenergetic systems in the brain and body", Front Neuroendocrinol, 35, pp.8~30 (2014)
81. Schwartz RS, "Handbook of obesity", pp.103~114 (1998), Marcel Dekker
82. Kotani K, "Sexual dimorphism of age-related changes in whole-body fat distribution in the obese", Int J Obes Relat Metab Disord, 18, pp.207~212 (1994)
83. Ley CJ, "Sex-and menopause-associated changes in body-fat distribution", Am J Clin Nutr, 55, pp.950~954 (1992)
84. Lovejoy JC, "Increased visceral fat and decreased energy expenditure during the menopausal transition", Int J Obes(Lond), 32, pp.949~958 (2008)
85. Link JC, "Genetic basis for sex differences in obesity and lipid metabolism", Annu Rev Nutr, 37, pp.225~245 (2017)
86. Yasuda M, "Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats", Hepatology, 29, pp.719~727 (1999)
87. Itagaki T, "Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells", Gut, 54, pp.1782~1789 (2005)
88. McKenzie J, "Effects of HRT on liver enzyme levels in women with type 2 diabetes:a randomized placebo-controlled trial", Clin Endocrinol (Oxf), 65, pp.40~44 (2006)
89. Fujihara Y, "High sex hormonebinding globulin concentration is a risk factor for high fibrosis-4index in middle-aged Japanese men", Endocr J, 66, pp.637~645 (2019)
90. Dunn JF, "Transport of steroid hormones : binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma", J Clin Endocrinol Metab, 53, pp.58~68 (1981)
91. Zitzmann M, "Testosterone deficiency, insulin resistance and the metabolic syndrome", Nat Rev Endocrinol, 5, pp.673~681 (2009)
92. Grossmann M, "Low testosterone in men with type 2 diabetes : significance and treatment", J Clin Endocrinol Metab, 96, pp.2341~2353 (2011)
93. Rao PM, "Testosterone and insulin resistance in the metabolic syndrome and T2DM in men", Nat Rev Endocrinol, 9, pp.479~493 (2013)
94. Ding EL, "Sex hormone-binding globulin and risk of type 2 diabetes in women and men", N Engl J Med, 361, pp.1152~1163 (2009)
95. Wu EM, "Gender differences in hepatocellular cancer : disparities in nonalcoholic fatty liver disease", steatohepatitis and liver transplantation, 2018, pp.4, 66~
96. Ascha MS, "The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", Hepatology, 51, pp.1972~1978 (2010)
97. Naugler WE, "Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production", Science, 317, pp.121~124 (2007)
98. Yang JD, "Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis", Hepatology, 59, pp.1406~1414 (2014)
99. Cusi K, "Nonalcoholic steatohepatitis in nonobese patients : not so different after all", Hepatology, 65, pp.4~7 (2017)
100. Fracanzani AL, "Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity", J Hepatol, 54, pp.1244~1249 (2011)
101. Alam S, "Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh", Indian J Gastroenterol, 33, pp.452~457 (2014)
102. Akyuz U, "Characterization of lean patients with nonalcoholic fatty liver disease : potential role of high hemoglobin levels", Scand J Gastroenterol, 50, pp.341~346 (2015)
103. Leung JC, "Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients", Hepatology, 65, pp.54~64 (2017)
104. Kim D, "Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease", Liver Int, 39, pp.332~341 (2019)

관련 논문AI추천